logo-loader
viewEmerald Clinics Ltd

Emerald Clinics gears up for an IPO

Emerald Clinics Ltd chief executive officer and managing director Dr Michael Winlo updates Proactive on the healthcare technology and services company’s science-driven and data-underpinned approach in the complex world of care.

The CEO spoke about what drives the company, how it creates wealth and about its business model as Emerald Clinics gears up for an IPO.

Quick facts: Emerald Clinics Ltd

Price: 0.072 AUD

ASX:EMD
Market: ASX
Market Cap: $13.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Emerald Clinics Ltd named herein, including the promotion by the Company of Emerald Clinics Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Emerald Clinics announce new collaborations to enhance and expand its...

Emerald Clinics Ltd's (ASX:EMD) Dr Michael Winlo speaks to Proactive's Andrew Scott after announcing they've signed new agreements that he says will enhance its data capture technology platform and support the launch of a new digital health and clinical monitoring service called ‘Sentinel...

on 22/6/20

2 min read